Maximus Inc (MMS) Stock Analysis

Verdict: BUY

Valuation discount (P/E 9.4x vs peers 19x) offers asymmetric upside as $660M Agile Defense deal drives expansion despite contract friction.

Investment score: 68/100

Analysis as of

Is Maximus Inc stock worth reviewing? The TradeMates thesis

TradeMates rates Maximus Inc (MMS) a BUY at $63.95. The company's low valuation (9.37x P/E, 7.01x EV/EBITDA) and robust free cash flow generation ($366.2M in FY25) offer significant downside protection. The acquisition of Agile Defense accelerates entry into high-margin government cybersecurity and IT programs, positioning MMS for earnings recovery toward consensus estimates of $8.36 EPS by FY27.

7-factor investment score

Maximus Inc opportunities and risks

What speaks for MMS

What speaks against MMS

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
MMS9.4x0.6x7.0x24.4%7.1%13.0%
BR19.1x2.8x12.1x31.8%15.0%6.3%
SSNC24.9x3.2x12.7x48.1%13.2%8.4%
EXLS26.8x2.9x15.5x38.5%11.2%4.3%
CNXCn/a0.2xn/a32.4%-24.0%28.2%
TASK7.3x0.6x4.9x34.0%8.8%15.2%
Peer median19.1x2.8x12.1x34.0%11.2%8.4%

Frequently asked questions about Maximus Inc (MMS)

Is MMS stock a good investment?

The TradeMates model rates Maximus Inc as BUY with an investment score of 68/100. TradeMates rates Maximus Inc (MMS) a BUY at $63.95. The company's low valuation (9.37x P/E, 7.01x EV/EBITDA) and robust free cash flow generation ($366.2M in FY25) offer significant downside protection. The acquisition of Agile Defense accelerates entry into high-margin government cybersecurity and IT programs, positioning MMS for earnings recovery toward consensus estimates of $8.36 EPS by FY27. This is algorithmic model output, not personal investment advice.

Is MMS stock a buy?

The TradeMates model verdict for MMS is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.